Skip to content

Clinical efficacy observation of pediatric massage combined with traditional Chinese medicine application in the treatment of allergic rhinitis with deficiency syndrome in children

Clinical efficacy observation of pediatric massage combined with traditional Chinese medicine application in the treatment of allergic rhinitis with deficiency syndrome in children

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053618
Enrollment
Unknown
Registered
2021-11-25
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Push medicine group:Pediatric massage combined with Chinese medicine plaster
Western medicine group:Oral administration of levocetirizine hydrochloride

Sponsors

Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Should meet the diagnostic criteria of allergic rhinitis and be classified as persistent moderate to severe; 2.Aged 2 to 12 years, no gender limitation; 3.The child did not take or receive drugs or treatments that have an impact on the disease during the observation and treatment period; 4.The child has good compliance and the guardian is willing to cooperate with the treatment; 5.Patients who voluntarily participate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Allergic to the drugs or tools involved in this experimental protocol; 2.Half a month before treatment, he had taken glucocorticoids, antihistamines, immunosuppressants, etc.; 3.Children with tuberculosis, bronchiectasis, and acute asthma; 4.Children with infectious diseases; 5.With acute attack of bronchial asthma, severe allergic conjunctivitis, chronic rhinosinusitis, upper airway cough syndrome, secretory otitis media, obstructive sleep apnea hypopnea syndrome (OSAHS) caused by adenoid hypertrophy or tonsil enlargement; 6.Obvious physiological and anatomical abnormalities of the nose. Note: patients with any of the above conditions can be excluded.

Design outcomes

Primary

MeasureTime frame
Visual analog scale for nasal major symptoms;Naso-ocular conjunctiva related quality of life questionnaire;Visual simulation scale of nasal concomitant symptoms;Evaluation table of main clinical symptoms and signs;Untargeted metabolomics of urine and nasal anterior turbinate secretions;

Countries

China

Contacts

Public ContactShao Ying
shaoying@gzucm.edu.cn+86 13580405528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026